Shandong Bainuo Pharmaceutical DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

FDA Approves First Medication for Obstructive Sleep Apnea

21 Dec 2024

// FDA

FDA approves Vertex Pharma's triple combo cystic fibrosis treatment

21 Dec 2024

// REUTERS

GSK's cancer drug combo meets main goal in ovarian cancer trial

21 Dec 2024

// REUTERS

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Pharma, Lab & Chemical Expo

Not Confirmed

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

About

Shandong Bainuo Pharmaceutical Co., Ltd. was established in August 2000 and is headquartered in Jinan City, Shandong Province. It is committed to building a leading pharmaceutical R&D technology platform company in China. It has passed the ISO9001 international quality management system and intellectual property management system certification, and established the "R&D Industry " Academician Workstation" , the vice-chairman unit of the Pharmaceutical Research and Development Branch of the All-China Federation of Industry and Commerce, and obtained the "Drug Production License" of the first research institution in Shandong Province.